Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | DBH | P09172 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10121174 | 0.87 | KDM4E (0.62) | KDM4EDBHGAARECQLLMNA | |
| SCHEMBL31533508 | 0.84 | PARP10 (0.45) | KDM4ELMNANPC1RAB9ACYP1A2 | |
| SCHEMBL9364482 | 0.84 | LMNA (0.44) | KDM4ELMNANPC1RAB9ACYP1A2 | |
| SCHEMBL20612569 | 0.84 | LMNA (0.73) | KDM4ELMNANPC1RAB9AMAPT | |
| SCHEMBL7377187 | 0.82 | SLC6A3 (0.42) | KDM4ELMNANPC1RAB9ACYP1A2 | |
| SCHEMBL4875754 | 0.81 | PARP10 (0.55) | KDM4EDBHGAARECQLCYP3A4 | |
| SCHEMBL195312 | 0.81 | CYP2C9 (0.53) | KDM4EDBHGAARECQLLMNA | |
| SCHEMBL10941943 | 0.80 | KDM4E (0.56) | KDM4EDBHGAARECQLLMNA | |
| SCHEMBL12418688 | 0.80 | KDM4E (0.56) | KDM4EDBHGAARECQLLMNA | |
| SCHEMBL19491813 | 0.80 | POLB (0.67) | LMNANPC1RAB9AMAPTAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | disclosed |
| US-20210318489-A1 | FIBER OPTIC INTEGRATED-LIGHT DIFFUSERS FOR SENSING APPLICATIONS | Khalifa University of Science and Technology (AE) | 2021-10-14 | — | — | US | disclosed |
| US-11143815-B1 | Fiber optic integrated-light diffusers for sensing applications | Khalifa University of Science and Technology (AE) | 2021-10-12 | — | — | US | disclosed |
| US-20210115191-A1 | POLYCARBONATE DIOL AND PRODUCING METHOD THEREOF, AND POLYURETHANE AND ACTIVE ENERGY RAY-CURABLE POLYMER COMPOSITION BOTH FORMED USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-04-22 | — | — | US | disclosed |
| US-10961197-B2 | Metal chelators for imaging, therapeutics, and bioanalysis | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2021-03-30 | — | — | US | disclosed |
| US-10947271-B2 | Antibacterial agents | THE UNIVERSITY OF QUEENSLAND (AU) | 2021-03-16 | — | — | US | disclosed |
| US-10907012-B2 | Polycarbonate diol and producing method thereof, and polyurethane and active energy ray-curable polymer composition both formed using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-02-02 | — | — | US | disclosed |
| US-10633470-B2 | Method of producing a conjugated diene polymer, a modified conjugated diene polymer, and a vinyl cis-polybutadiene composition | UBE INDUSTRIES, LTD. (JP) | 2020-04-28 | — | — | US | disclosed |
| US-10508163-B2 | Conjugated diene polymer and modified conjugated diene polymer produced using the same, rubber composition for tire, and rubber composition for rubber belt | UBE INDUSTRIES, LTD. (JP) | 2019-12-17 | — | — | US | disclosed |
| CN-107266328-B | Oligomeric amino ketones and its purposes as photoinitiator | 太阳化学公司 | 2019-11-19 | — | — | CN | disclosed |
| EP-0907650-B1 | N- 4-(HETEROARYLMETHYL)PHENYL]-HETEROARYLAMINES | JANSSEN PHARMACEUTICA NV (BE) | 2002-12-04 | — | — | EP | disclosed |
| US-6486187-B1 | N-[4-(heteroarylmethyl)phenyl]-heteroarylamines | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-11-26 | — | — | US | disclosed |
| EP-1175406-A1 | IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2002-01-30 | — | — | EP | disclosed |
| WO-2000066563-A1 | IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2000-11-09 | — | — | WO | disclosed |
| US-6124330-A | A RETINOIC MIMETIC COMPOUND FOR TREATING A WARM-BLOODED ANIMAL SUFFERING FROM A DISEASE BY AN ABNORMAL PROLIFERATION AND/OR ABNORMAL DIFFERENTIATION OF NORMAL, PRENEOPLASTIC OR NEOPLASTIC CELLS | JANSSEN-CILAG S.A. (FR) | 2000-09-26 | — | — | US | disclosed |
| EP-0712622-B1 | Dental composition and kit | TOKUYAMA CORP (JP) | 1999-09-01 | — | — | EP | disclosed |
| US-5925690-A | UNSATURATED PHOSPHATE AND UNSATURATED POLYCARBOXYLIC ACID MONOMERS; BONDING AND TENSILE STRENGTH TO DENTIN AND ENAMEL | TOKUYAMA CORPROATION (JP) | 1999-07-20 | — | — | US | disclosed |
| EP-0907650-A1 | N- 4-(HETEROARYLMETHYL)PHENYL]-HETEROARYLAMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049704-A1 | N-[4-(HETEROARYLMETHYL)PHENYL]-HETEROARYLAMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-12-31 | — | — | WO | disclosed |
| EP-0712622-A1 | Dental composition and kit | TOKUYAMA CORPORATION (JP) | 1996-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115191-A1 | POLYCARBONATE DIOL AND PRODUCING METHOD THEREOF, AND POLYURETHANE AND ACTIVE ENERGY RAY-CURABLE POLYMER COMPOSITION BOTH FORMED USING SAME | DIMT1, CAD, PUF60 | KDM4E 1385/4885DBH 3271/4885GAA 3295/4885 |
| US-10907012-B2 | Polycarbonate diol and producing method thereof, and polyurethane and active energy ray-curable polymer composition both formed using same | PUF60, DIMT1, XRCC6 | KDM4E 1295/4885DBH 2422/4885GAA 2479/4885 |
| US-10947271-B2 | Antibacterial agents | VNN1, ASNS, AAAS | KDM4E 4327/4885DBH 3559/4885GAA 258/4885 |
| US-10961197-B2 | Metal chelators for imaging, therapeutics, and bioanalysis | TBCA, SLC39A3, TBL3 | KDM4E 2013/4885DBH 2024/4885GAA 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.